SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-23-016569
Filing Date
2023-06-05
Accepted
2023-06-05 09:00:29
Documents
1
Period of Report
2023-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 3799
  Complete submission text file 0001437749-23-016569.txt   5209
Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35610 | Film No.: 23991369

Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Issuer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations